Table 2 Some diseases and therapeutics involving both miRNA and eRNA
From: Enhancer RNAs: transcriptional regulators and workmates of NamiRNAs in myogenesis
Diseases and therapeutics | miRNA | eRNA |
|---|---|---|
General cell signaling pathway | miRNAs [75] | NET1e [87] |
MAP kinases and NFkB | miR-22 and miR-140 [91] | ADAMDEC1 eRNA[22] |
Adenocarcinoma | miR-3131, miR-664, miR-483 and miR-150 [92] | NET1e, general eRNAs [87] |
Cancer | eRNAs of BRCA [87] | |
Prostate cancer | miR-373 [51] | KLK3e [10] |
Tumor suppression | miR-17-92 [89] | p53BERs eRNAs [11] |
Apoptosis and tumorigenesis | ||
Immunity | miR-212 [100] | AP001056.1 [101] |
Breast cancer | miR-200b ~ 200a ~ 429 [90] | miR-200b eRNA [90], NET1e [87] estrogen receptor α (ER-α)-bound eRNA( +) [102] |
Drug resistance | miR-17 [86] | NET1e [87] |